Showing results (1411-1420 of 1,526) with videos related to

Sort By:
Pageof 153
The Journal of Experimental Medicine|November 19, 2020
Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivoAlexandra Schäfer, Frauke Muecksch, Julio C C Lorenzi, et al.
Journal of American College Health : J of ACH|June 8, 2023
The role of personal identity as a resource for college students during COVID-19Seth J Schwartz, Beyhan Ertanir, Audrey Harkness, et al.
Neuro-Oncology|January 5, 2002
Response of rat intracranial 9L gliosarcoma to microbeam radiation therapyF Avraham Dilmanian, Terry M Button, Géraldine Le Duc, et al.
Nature Communications|July 7, 2016
Envelope-specific B-cell populations in African green monkeys chronically infected with simian immunodeficiency virusRuijun Zhang, David R Martinez, Quang N Nguyen, et al.
European Journal of Plastic Surgery|October 4, 2022
Bromelain-based enzymatic burn debridement: Spanish multidisciplinary consensusJordi Serracanta, Jacinto Baena, José R Martinez-Mendez, et al.
Cancer|August 19, 2021
Cardiac remodeling after anthracycline and radiotherapy exposure in adult survivors of childhood cancer: A report from the St Jude Lifetime Cohort StudyJohn L Jefferies, Wojciech M Mazur, Carrie R Howell, et al.
Journal of Medicinal Chemistry|August 4, 2021
Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CL<sup>pro</sup>)Sang Hoon Han, Christopher M Goins, Tarun Arya, et al.
Children (Basel, Switzerland)|December 24, 2021
Pediatric Cardio-Oncology Medicine: A New Approach in Cardiovascular CareHugo R Martinez, Gary S Beasley, Jason F Goldberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2020
Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infectionWei Li, Chuan Chen, Aleksandra Drelich, et al.
Plos One|July 6, 2017
V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144Lautaro G Perez, David R Martinez, Allan C deCamp, et al.
Pageof 153